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Summary
 
Mice lacking the interleukin 7 receptor (IL-7R) generate 
 
a
 
/
 
b
 
 T cells at a detectable but greatly
reduced rate, but 
 
g
 
/
 
d
 
 T cells are completely absent. The special role of IL-7R signaling in 
 
g
 
/
 
d
 
T cell development has remained unclear. IL-7R
 
a
 
2
 
/
 
2
 
 mice exhibit a paucity of 
 
g
 
 gene rear-
rangements. This striking observation can be explained by a defect in T cell receptor (TCR)-
 
g
 
gene rearrangement, a defect in TCR-
 
g
 
 gene transcription leading to death of 
 
g
 
/
 
d
 
 lineage
cells, and/or a requirement for IL-7R in commitment of cells to the 
 
g
 
/
 
d
 
 lineage. To determine
the role of IL-7R signaling in 
 
g
 
/
 
d
 
 T cell development, we examined transcription of a prerear-
ranged TCR-
 
g
 
 transgene in IL-7R
 
a
 
2
 
/
 
2
 
 mice, as well as the effects of IL-7 on transcription of
endogenous, rearranged TCR-
 
g
 
 genes in 
 
a
 
/
 
b
 
 lineage cells. The results demonstrate that IL-
7R–mediated signals are necessary for the normal expression of rearranged TCR-
 
g
 
 genes.
Equally significant, the results show that the poor expression of TCR-
 
g
 
 genes in IL-7R
 
a
 
2
 
/
 
2
 
mice is responsible for the selective deficit in 
 
g
 
/
 
d
 
 cells in these mice, since a high copy TCR-
 
g
 
transgene exhibited sufficient residual expression in IL-7R
 
a
 
2
 
/
 
2
 
 mice to drive 
 
g
 
/
 
d
 
 cell devel-
opment. The results indicate that the absence of 
 
g
 
/
 
d
 
 T cells in IL-7R
 
a
 
2
 
/
 
2
 
 mice is due to insuf-
ficient TCR-
 
g
 
 gene expression.
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I
 
nterleukin (IL)-7 is crucial for the survival and normal
differentiation of lymphocytes. It is produced by bone
marrow and thymic stromal cells from embryonic day 12
onward (1). IL-7R expression is first detected on the lym-
phoid lineage-restricted progenitor in the bone marrow
(2). Subsequent immature intermediates in T cell develop-
ment express it at varying levels. The IL-7R complex con-
sists of at least two subunits, the unique IL-7R
 
a
 
 chain and
the common 
 
g
 
 (
 
g
 
c) chain that is also a component of the
high-affinity receptors for IL-2, -4, -9, and -15 (3).
IL-7 appears to play a role at multiple stages of T and B
lymphocyte development. Analysis of mice deficient for
IL-7 (4) or its receptor (5–7) demonstrates that the cyto-
kine is indispensable for the normal maintenance and pro-
liferation of early thymic progenitor cells, before expression
of the TCR. For example, IL-7
 
2
 
/
 
2
 
 mice exhibit a 20-fold
reduction in the number of CD25
 
1
 
CD44
 
1
 
CD4
 
2
 
CD8
 
2
 
pro-T cells (8), and a corresponding reduction in thymus
cellularity (4). Nevertheless, some development of mature
T cells occurs in IL-7
 
2
 
/
 
2
 
 mice, such that the percentages of
 
a
 
/
 
b
 
 lineage thymic subsets, including CD4
 
1
 
CD8
 
1
 
 double
positive (DP)
 
1
 
 cells and mature CD4
 
1
 
 and CD8
 
1
 
 single
positive (SP) cells, are near normal (4, 8). In contrast, the
proportion of TCR-
 
g
 
/
 
d
 
1
 
 thymocytes is strongly reduced
in IL-7
 
2
 
/
 
2
 
 mice (8), consistent with previous in vitro ex-
periments that suggested a specific function of IL-7 in 
 
g
 
/
 
d
 
T lineage development separate from its function in early T
cell progenitors (9, 10).
Like IL-7
 
2
 
/
 
2
 
 mice, induced mutant mice with defective
genes encoding for IL-7R
 
a
 
 (5), 
 
g
 
c (6, 7), or Janus kinase
(JAK)3 (11–13), a kinase involved in IL-7R signal trans-
duction, exhibit substantially reduced numbers of mature
lymphocytes. However, the phenotypes of the IL-7R
 
a
 
2
 
/
 
2
 
and 
 
g
 
c
 
2
 
/
 
2
 
 mice are more extreme. The number of 
 
a
 
/
 
b
 
lineage T cells is more noticeably decreased (30–40-fold),
and 
 
g
 
/
 
d
 
 T cells are completely absent (14, 15). The more
 
1
 
Abbreviations used in this paper:
 
 B6, C57BL/6; DN, CD4
 
2
 
CD8
 
2
 
 double
negative; DP, CD4
 
1
 
CD8
 
1
 
 double positive; HSA, heat-stable antigen;
JAK, Janus kinase; RAG, recombination activating gene; RT, reverse
transcription; SP, CD4
 
1
 
 or CD8
 
1
 
 single positive; STAT, signal trans-
ducer and activator of transcription. 
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severe effects of mutations in the receptor compared with
mutations in the cytokine have led to the proposal that an-
other cytokine can also interact with the IL-7R (5).
The finding that mutations in IL-7 and its receptor have
a more profound effect on 
 
g
 
/
 
d
 
 T cell development than
 
a
 
/
 
b
 
 T cell development has led to the suggestion that the
role of IL-7 is not limited to supporting the survival and
proliferation of uncommitted T cell progenitor cells, and
that it might play a unique role in 
 
g
 
/
 
d
 
 T cell development.
This conclusion was bolstered by the finding that 
 
a
 
/
 
b
 
 T
cell development was restored in IL-7R
 
2
 
/
 
2
 
 mice by consti-
tutive expression of the antiapoptotic gene 
 
bcl-2
 
, whereas
 
g
 
/
 
d
 
 T cell development was not (16, 17). This result sug-
gested that the IL-7R provides a survival signal during early
 
a
 
/
 
b
 
 T cell development. Importantly, the failure of Bcl-2
expression to restore 
 
g
 
/
 
d
 
 T cell development suggests that
the IL-7R provides a necessary and distinct type of signal in
 
g
 
/
 
d
 
 T cell development.
The specific role of the IL-7R in 
 
g
 
/
 
d
 
 T cell develop-
ment is controversial (18). It has been suggested that IL-
7R–mediated signals facilitate TCR-
 
g
 
 gene rearrangement
and/or transcription (10, 19–21), possibly by inducing and
maintaining open chromatin structure at the locus. In vitro
experiments using fetal or adult lymphocyte precursors
have shown that the addition of IL-7 in culture leads to in-
creased levels of TCR-
 
b
 
 and -
 
g
 
 gene rearrangements (10,
22). In young adult IL-7R
 
a2/2 mice, TCR-d, -b, and -a
genes were rearranged to a similar or a marginally reduced
level to that seen in normal mice, but TCR-g gene rear-
rangements were reported to be absent or selectively re-
duced for some Vg genes but not others (19, 21). In young
adult  gc2/2 mice, TCR-g, but not -d, gene rearrange-
ments were decreased significantly, but not all Vg genes
were affected to the same degree (20).
It has been reported that TCR-g gene rearrangements
may not be completely abrogated in IL-7Ra2/2 mice, but
rather that the rearranged TCR-g genes in these mice are
not transcribed (21). The functional relevance of the low
levels of TCR-g gene rearrangement in IL-7Ra2/2 mice
in this study is not known. Hence, the relative contribu-
tions of IL-7R–mediated signals to TCR-g gene rear-
rangement, as opposed to transcription of the rearranged
TCR-g genes, are not clear. Since TCR-g/d1 thymocytes
are not present in IL-7Ra2/2 mice, it is difficult to directly
assess the role of IL-7R–mediated signals in TCR-g gene
transcription in g/d lineage thymocytes. As a whole, al-
though the data suggest that the IL-7R plays an important
role in inducing TCR-g gene rearrangements and/or tran-
scription, it remains possible that the observed effects are
partly or even wholly due to the preferential survival or
proliferation of a thymic subset in which rearrangement/
transcription occurs.
Several nonexclusive mechanisms can be considered to
account for the selective absence of g/d T cells in IL-
7Ra2/2 mice. First, lack of IL-7R–mediated signaling re-
sults in a selective loss of g/d lineage–committed pro-T
cells. Second, TCR-g and/or -d gene rearrangements are
impaired in IL-7R2/2 mice, leading to a block in g/d lin-
eage commitment and/or development. Third, the TCR-
g/d genes rearrange normally, but transcription of the rear-
ranged genes requires IL-7R–mediated signaling, in the
absence of which g/d thymocytes fail to differentiate. Finally,
mature g/d thymocytes, or at least certain subsets of mature
g/d thymocytes, absolutely require IL-7R–mediated sig-
naling to survive and/or proliferate. As one means to dis-
tinguish among these possibilities, we have introduced a
prerearranged TCR-g transgene into IL-7Ra2/2 mice. By
providing a prerearranged gene, we can circumvent any ef-
fects of IL-7R–mediated signals on TCR-g gene rear-
rangement. The results clearly demonstrate that IL-7R–
mediated signaling is necessary for optimal transcription of
a rearranged TCR-g gene. Nevertheless, significant trans-
gene transcription occurred in a high copy transgenic IL-
7Ra2/2 line, resulting in a rescue of g/d T cell develop-
ment. Hence, the selective defect in g/d cell development
in IL-7R2/2 mice is due to effects on TCR-g gene tran-
scription and attendant effects on recombination.
Materials and Methods
Mice. G8 TCR-g transgenic mice have been characterized
previously (23). C57BL/6 (B6), B6 IL-7Ra2/2, and B6 recom-
bination activating gene (RAG)-12/2 mice were purchased from
The Jackson Laboratory. G8 TCR-g transgenic mice that had
been backcrossed to B6 mice at least three times were crossed to
IL-7Ra2/2 mice to generate TCR-g transgenic1 or transgenic2
IL-7R2/2 or IL-7R1/2 littermates. Mice were typed by PCR
using published primers and by flow cytometric analysis of pe-
ripheral blood lymphocytes. Mice were bred and maintained in
specific pathogen-free facilities at the University of California,
Berkeley.
Antibodies, Flow Cytometry, and Cell Culture. Anti-Vg2 TCR
(UC3-10A6), anti–TCR-d (GL3), anti–TCR-b (H57), anti-
CD5 (53-7.3), anti-NK1.1 (PK136), and anti–heat-stable antigen
(anti-HSA; J11d) mAbs were purified and conjugated with FITC
or biotin according to standard protocols. Anti-CD8a–Tricolor
(53-6.7), anti-CD44–FITC (IM7.8.1), and anti-CD25–PE
(PC61.5.3) mAbs were purchased from Caltag; anti-CD4–
Red613 was from GIBCO BRL; and streptavidin-PE was from
Molecular Probes. Red blood cell–lysed single cell suspensions of
thymocytes and splenocytes were stained with the relevant anti-
bodies at saturating concentrations, and 1–2 3 105 labeled cells
(side and forward gated) were analyzed by four-color cytometry
using an EPICS® XL-MCL flow cytometer (Beckman Coulter).
In some cases, splenocytes were passed through nylon wool to
enrich for T cells before antibody staining. Cells were sorted us-
ing an ELITE® cell sorter (Beckman Coulter). Flow cytometric
profiles were analyzed using the WinMDI program (John Trot-
ter, Salk Institute, San Diego, CA.).
Induction of TCR-g gene expression in mature a/b thy-
mocytes was carried out by culturing sorted mature (HSAlo)
CD41 or CD81 a/b (TCR-bhi) thymocytes along with g/d thy-
mocytes in complete medium (RPMI 1640 supplemented with
10% FCS, 50 mM 2-ME, 2 mM l-glutamine, 20 mM Hepes, and
antibiotics) containing recombinant IL-2 (5 ng/ml; Chiron) with
or without IL-7 (2–100 ng/ml recombinant murine IL-7 [Gen-
zyme] or 1% IL-7 supernatant from J558 plasmacytoma trans-
fected with an expression vector containing IL-7 cDNA [24]) for
5 h to 4 d. Each sorting experiment used three to six B6 mice975 Kang et al.
(4–8-wk-old) and involved depletion of HSAhi cells using a mag-
netic-activated cell sorter (MACS) before cell sorting.
Southern Blot Analysis. Genomic DNA (gDNA) isolation and
Southern blotting were carried out as described (25). 15 mg of
gDNA was digested (except for the sample from RAG-12/2
mice, which represents 2 mg of gDNA) with EcoRI, electro-
phoresed on 0.7% agarose gels, and blotted. The blot was hybrid-
ized with a Cg1 probe that cross-hybridizes with Cg2 and Cg3
genes (26).
RNase Protection Assay. [a-32P]rUTP (Amersham Pharmacia
Biotech)–labeled riboprobe specific for the TCR-g transgene
transcripts was generated from a linearized pKS Bluescript vector
(Stratagene) containing the 273-bp KpnI-BsrI fragment that in-
cludes the V-J junction sequence of G8 transgene under the con-
trol of T7 promoter. Control riboprobe specific for g-actin
mRNA was generated using SP6 RNA polymerase. RNase pro-
tection assay was carried out essentially as described (25) using 5 mg
of total RNA purified from sorted thymocyte populations (a pool
of 9–15 IL-7Ra2/2 mice per transgenic line was used in two in-
dependent sorting experiments). RNA was isolated using Ul-
traspec RNA solution (Biotecx). Each sample contained both
probes to eliminate quantitative variations in input RNA. Densi-
tometric analysis was performed using a PhosphorImager (Molec-
ular Dynamics).
Reverse Transcription PCR. Reverse transcription (RT) of 1–2
mg of total RNA from sorted (and cultured) thymocytes was per-
formed using oligo-dT primers and avian reverse transcriptase
(both from Boehringer Mannheim). Each sorting experiment
used pooled thymocytes from four to eight IL-7Ra2/2 mice for
the analysis of transgene expression and pooled thymocytes from
three to six B6 mice for the analysis of endogenous TCR-g gene
expression in a/b cells. cDNA was serially diluted 3- or 4-fold,
and PCR was performed for 28 cycles with the addition of 1.0
mCi of [a-32P]dCTP (Amersham Pharmacia Biotech) per sample
in a total reaction volume of 50 ml. Samples without the RT step
were subjected to the same PCR protocol. Starting sample con-
centration of tubulin PCR reactions was three- or fourfold lower
than the corresponding target gene PCRs. Products were re-
solved by gel electrophoresis on a 5% polyacrylamide gel and vi-
sualized by autoradiography. Densitometric analysis was per-
formed using a PhosphorImager (Molecular Dynamics). For
nonradioactive PCR, 35–39 cycles of amplification were per-
formed. Products were subjected to gel electrophoresis on a 1.5%
agarose gel and visualized by ethidium bromide staining. The fol-
lowing PCR primers were used: 59 Vg2, CTGGGAATTCAA-
CCTGGCAGATGA; 39 J g1, GGGAAGCTTACCAGAGG-
GAATTACTATGAG; 39 G8 junction, GTGAAAACCTGAG-
CTCCCCTCCC; 59 tubulin, CAGGCTGGTCAATGTGGC-
AACCAGATCGGT; 39 tubulin, GGCGCCCTCTGTGTAG-
TGGCCTTTGGCCCA.
Results
Impaired TCR-g Transgene Expression in IL-7R–deficient
Mice. The TCR-g gene rearrangement status in IL-
7Ra2/2 mice has been somewhat controversial. Southern
blot analysis of TCR-g gene rearrangement in thymocytes
demonstrated that the rearranged TCR-g genes are virtu-
ally undetectable in IL-7Ra2/2 mice and that the pattern is
very similar to that observed in RAG-12/2 mice (Fig. 1).
This result supports previous Southern analysis (19) but is
in contrast to the recent PCR data that indicated a signifi-
cant level of TCR-g gene rearrangement in IL-7Ra2/2
mice (21). This deficiency in TCR-g gene rearrangement
can be caused by a specific defect in TCR-g gene rear-
rangement/transcription and/or a selective loss of cells that
rearrange/transcribe TCR-g genes.
To investigate the role of IL-7R signaling in TCR-g
gene expression, we crossed TCR-g transgenes onto an
IL-7Ra2/2 background. The use of a prerearranged trans-
gene allowed us to examine TCR-g gene expression inde-
pendent of TCR-g gene recombination. Two distinct a/b
lineage developmental phenotypes of IL-7Ra2/2 mice
have been documented: in type I IL-7Ra2/2 mice the thy-
mus is composed exclusively of immature CD42CD82
(double negative [DN]) thymocytes (5), whereas in type II
mice they exhibit near normal CD4/CD8 thymic compo-
sition (14). The basis for the phenotypic variation is un-
known. All IL-7Ra2/2 mice lack g/d T cells and show a
drastically decreased thymic cellularity. In our colony, the
majority of the B6 IL-7Ra2/2 mice (.80%) exhibit the
type II phenotype.
Mice harboring a productively rearranged TCR-g
(Vg2-Jg1-Cg1) transgene (27) from the G8 cell line have
been described previously (23). It has been demonstrated
that expression of this transgene correlates well with trans-
gene copy number and is not subject to transgene position
effects (23, 28). We compared 2 TCR-g transgenic lines
containing the identical transgene, but with different num-
bers of transgene copies (30 vs. 2 copies). Expression levels
were determined in RNA samples from sorted (.99%
pure) CD42CD82TCR-b2 thymocytes, with an RNase
protection assay using a V-J junction spanning probe spe-
cific for the transgene (Fig. 2 A). The results were normal-
Figure 1. Lack of significant TCR-g gene rearrangement in thy-
mocytes of IL-7Ra2/2 mice. Southern blot analysis of EcoR1-digested
genomic DNA probed with a Cg-specific probe reveals a virtually unde-
tectable level of TCR-g gene rearrangement in thymocytes of IL-7Ra2/2
mice. Three germline bands at 13.4, 10.5, and 7.5 kb detected in the
RAG-12/2 lane represent unrearranged J-C gene segments of Cg1, Cg2,
and Cg3 loci, respectively. Cg3 gene segment is a pseudogene and is
found mostly in the germline configuration in normal thymocytes. Rear-
ranged Cg genes migrate at 16–20 kb, representing two predominant
gene rearrangements, Vg2-Jg1-Cg1 and Vg1.2-Jg2-Cg2, found in adult
thymocytes. The RAG-12/2 lane contains approximately eightfold less
digested genomic DNA than the other two lanes. Numbers on the right
represent DNA sizes (in kb).976 IL-7 Receptor Signals Regulate TCR-g Gene Transcription
ized with reference to an internal g-actin control. In addi-
tion, semiquantitative RT-PCR was performed using
transgene-specific primers (Fig. 2 B).
The low copy TCR-g transgene is expressed in the nor-
mal thymus at similar levels as the endogenous TCR-g
genes in a g/d T cell hybridoma (29; Kang, J., and D.H.
Raulet, unpublished results). Transgene transcript levels
were reduced by .26-fold in CD42CD82TCR-b2 thy-
mocytes from the low copy transgenic IL-7Ra2/2 mice
compared with control transgenic IL-7Ra1/2 thymocytes
(Fig. 2 A). The dramatic reduction in transgene transcrip-
tion was confirmed in highly sensitive RT-PCR experi-
ments. In two out of three such experiments, no transgene
transcripts were detected in sorted CD42CD82TCR-b2
thymocytes from transgenic IL-7Ra2/2 mice, whereas
abundant transcripts were detected in transgenic IL-7Ra1/2
mice (for example, see experiment 1 [EXP’T 1] in Fig. 2
B). In one experiment, transcripts were detected in sorted
thymocytes from IL-7Ra2/2 mice, but the levels were re-
duced by more than eightfold compared with IL-7Ra1/2
mice (Fig. 2 B, experiment 2). This level of transgene tran-
scription was only detectable in one experiment, and only
in the PCR assay.
The high (30) copy transgene was expressed at much
higher levels in transgenic IL-7Ra1/2 thymocytes than the
low copy transgene, as expected from the greater number
of transgene copies (Fig. 2 A). Nevertheless, transgene
mRNA levels were substantially reduced in sorted thy-
mocytes from IL-7Ra2/2 transgenic mice, by a factor of at
least five- to sevenfold (Fig. 2 A). No significant difference
was seen between samples from transgenic IL-7R1/1 and
IL-7R1/2 mice (data not shown). The less dramatic effects
of IL-7R deficiency on transgene transcription in the high
copy line may be due to cooperative effects of multiple
tandem transgene copies, which may partly overcome the
requirement for IL-7R–dependent factors. Taken together,
the results demonstrate that the transcription of both high
and low copy TCR-g transgenes is highly dependent on
IL-7Ra expression.
The High Copy TCR-g Transgene Rescues g/d T Cell
Development in IL-7R2/2 Mice. Although optimal TCR-g
gene transcription depended on IL-7R signaling, the high
copy TCR-g transgene supported significant levels of
transgene transcription. This persistent but reduced trans-
gene transcription was likely due in part to the higher
number of templates for transcription as well as to a partial
reduction in IL-7R dependence due to tandem multimer-
ization of the transgene. The significant expression of the
transgene in the high copy line allowed us to address
whether the absence of g/d cells in IL-7Ra2/2 mice is due
to the absence of TCR-g chain synthesis.
It was shown previously that in otherwise normal mice,
TCR-g transgene expression resulted in a two- to three-
fold enhancement in the development of g/d thymocytes.
The resulting g/d cell population was .90% Vg21 com-
pared with z40% Vg21 thymocytes in nontransgenic lit-
termates (23; Fig. 3 A). The increase in g/d cell numbers in
the transgenic mice was independent of transgene copy
Figure 2. Expression of rearranged TCR-g transgene in thymocyte
precursors is dependent on IL-7R signaling. (A) A representative RNase
protection assay of transgene-specific RNA in purified
CD42CD82TCR-b2 thymocytes from high (.30) and low (,2) copy
transgenic IL-7Ra1/2 (designated 1) and IL-7Ra2/2 (2) mice using the
transgene V-J junction–specific riboprobe. Labeled, undigested probes are
shown on the right (gA, g-actin; v2, G8 VJ junction–specific probe).
Identities of the protected bands are indicated beside the arrows. The two
protected bands marked as originating from G8 TCR-g gene template
(G8 Vg2) at 273 and 249 bp are so designated based on the predicted sizes
of the protected VJ region of the G8 mRNA and are only detected in
transgenic RNA samples. Size markers were included in all of the gels.
The 249-bp fragment corresponds to correctly spliced mRNA, and the
273-bp fragment represents an mRNA in which the correct J-C splice has
not occurred. Numbers below the panel represent the degrees of reduc-
tion in transgene-specific RNA level (combined quantities of two bands
marked as G8g) in transgenic IL-7Ra2/2 mice compared with IL-7Ra1/2
mice as determined by the PhosphorImager densitometric analysis with
g-actin RNA level as a loading control. Numbers on the right represent
RNA sizes (in bp). Sub-bands present in the high copy IL-7R1 lane are
transgene transcription specific and may originate from incorrect splicing,
aberrant transcription, and/or unstable mRNA, and are possibly en-
hanced by an abnormally elevated expression of the transgene. (B) Semi-
quantitative RT-PCR assay for transgene-specific RNA in purified
CD42CD82TCR-b2 thymocytes from low copy transgenic IL-7Ra1/2
and IL-7Ra2/2 mice. Results from fourfold serial dilutions of the cDNA
samples used for PCR are shown. Tubulin RT-PCR was used as a con-
trol. The highest initial amount used for tubulin PCR was fourfold di-
luted compared with the highest amount used for Vg2-G8 junction–spe-
cific PCR. No significant level of product was detected in PCR reactions
without the RT step, and no RT-PCR product was detectable in non-
transgenic samples (data not shown). Results from two of three indepen-
dent sorting experiments are shown.977 Kang et al.
number, but was dependent on the production of func-
tional endogenous TCR-d chains.
g/d T cells were not detectable in IL-7Ra2/2 mice (14,
15). The rearranged TCR-g transgene, when present at 30
transgene copies, rescued g/d T cell (CD42, CD82,
CD5med, TCR-b2, NK1.12, HSAlo to hi; data not shown)
development in the thymus of IL-7Ra2/2 mice (Fig. 3 A).
The proportion of DN thymocytes that expressed TCR-
g/d in transgenic IL-7Ra2/2 mice (20.6 6 1.8%) was sim-
ilar to that of transgenic littermates that were IL-7Ra1/2
or IL-7Ra1/1 (19.3 6 2.4%, Fig. 3 A). Moreover, the pro-
portion of the DN thymocytes that were HSAloTCR-g/d1,
a provisional phenotype for mature T cells, did not differ
significantly between transgenic IL-7Ra2/2 mice and
wild-type mice (data not shown). The cells were stained
with an anti–TCR-d mAb, indicating that d chain expres-
sion is independent of IL-7R signaling.
Although the percentage of g/d thymocytes in trans-
genic IL-7Ra2/2 mice was normal, the absolute number
of these cells was reduced z14-fold at 4–5 wk of age com-
pared with transgenic IL-7Ra1/2 mice. This is to be ex-
pected, given the .20-fold reduction in the number of
T lineage–committed progenitor cells (CD251CD441
c-kit1CD42CD82CD32) in these mice (17; Fig. 3 B, and
data not shown). Hence, the absolute number of g/d thy-
mocytes generated per progenitor T cell in the transgenic
IL-7Ra2/2 mice was not substantially different from that
in normal mice. Examination of DN developmental inter-
mediates using CD25/CD44 expression revealed no signif-
icant alterations in the subset distribution between the
transgenic and nontransgenic IL-7Ra2/2 littermates, and a
distinct CD251CD442 DN pre-T cell subset was not evi-
dent even when the transgene was expressed (Fig. 3 B,
middle panel).
Peripheral g/d T cells were essentially undetectable in
nontransgenic IL-7Ra2/2 mice (14, 15; Table I). Signifi-
cant numbers of peripheral g/d T cells were detected in
transgenic IL-7Ra2/2 mice older than 3 wk, although they
were reduced in absolute cell number by z13-fold com-
pared with transgenic IL-7Ra1/2 mice (Table I), as might
be expected considering the reduction in thymic progeni-
tor cells in these mice. These observations suggest that IL-7R
Figure 3. Expression of a rearranged TCR-g gene results in g/d T cell
development in IL-7Ra2/2 mice. (A) Proportions of gated CD42CD82
DN thymocytes expressing TCR-g/d in representative nontransgenic
B6, high copy transgenic B6, high copy transgenic B6 IL-7Ra2/2, and
nontransgenic B6 IL-7Ra2/2 littermate mice. Transgenic mice predomi-
nantly express TCR-g/d composed of G8 Vg2 chain. Numbers in brack-
ets represent total thymocyte number. (B) CD25/CD44 expression pro-
files of total and gated DN and DP thymocytes in high copy transgenic
IL-7Ra1/1 or IL-7Ra2/2 mice. No significant difference is seen in the
CD25/CD44 subset distribution between the nontransgenic and trans-
genic IL-7R1/1 mice. Tg, transgenic.
Table I. g/d T Cell Development in High Copy TCR-g Transgenic IL-7Ra2/2 Mice
Genotype* n (age, wk)
Cell no. (3105)
All thymocytes Thymic g/d Splenic g/d
average 6 SD
IL-7Ra1/2, Tg2 4 (3–5) 2,158 6 420 4.3 6 1.2 7.2 6 1.4
IL-7Ra1/2, Tg1 11 (3–5) 1,723 6 294 10.2 6 2.8 21.5 6 3.2‡
IL-7Ra2/2, Tg2 10 (2–3) 38 6 17 ,0.003§ ,0.01§
IL-7Ra2/2, Tg1 8 (2–3) 14 6 5 0.22 6 0.10 0.07 6 0.06‡
IL-7Ra2/2, Tg2 16 (4–5) 49 6 22 ,0.01§ ,0.01§
IL-7Ra2/2, Tg1 12 (4–5) 35 6 26 0.69 6 0.36 1.6 6 0.5i
*Tg, prerearranged TCR-g transgene.
‡n 5 5.
§Estimate based on maximal number detected within groups.
in 5 6.978 IL-7 Receptor Signals Regulate TCR-g Gene Transcription
signaling is not absolutely required for g/d T cell mainte-
nance in the periphery.
Collectively, the results indicate that sufficient expression
of a rearranged TCR-g gene alone can lead to the devel-
opment of g/d thymocytes in the absence of IL-7R–medi-
ated signals. Production of endogenous TCR-d chains was
not dependent on IL-7R. However, it cannot be ruled out
that a subtle difference in endogenous TCR-d gene tran-
scription exists in IL-7R2/2 mice, although such a differ-
ence is not expected to affect functional TCR-d chain gen-
eration. Importantly, the level of TCR-g/d receptors on
the surface of the transgenic thymocytes was no higher
than the receptor levels on g/d cells in normal mice (23;
and Fig. 3 A), suggesting that g/d T cell development in
the transgenic IL-7Ra2/2 mice is not due to aberrantly
enhanced TCR-g/d signaling. These results argue against
the possibility that IL-7R–mediated signals are essential for
the survival and/or maintenance of g/d T cells. Instead, the
data suggest that an IL-7R-mediated signal(s) is necessary
for the synthesis of TCR-g chains.
The Low Copy Transgene Fails to Rescue g/d T Cell Devel-
opment in IL-7Ra2/2 Mice. To determine whether the
rescue of g/d T cells in IL-7Ra2/2 mice is related to trans-
gene copy number, the low (2) copy transgenic IL-7Ra2/2
mice were analyzed. Flow cytometric analysis of DN thy-
mocytes confirmed that the low copy transgene expression
enhanced  g/d T cell development in IL-7Ra1/2 mice
(Fig. 4), similar to what was observed with the high copy
line (Fig. 3). However, unlike the high copy line, provision
of the low copy transgene failed to rescue g/d cell develop-
ment in IL-7Ra2/2 mice (Fig. 4). These data indicate that
the impaired transcription of the rearranged transgene in
low copy IL-7Ra2/2 mice results in levels of TCR-g
chain synthesis that are too low to stimulate g/d T cell de-
velopment.
IL-7 Can Reverse Transcriptional Suppression of the TCR-g
Gene in a/b Lineage Thymocytes. TCR-g genes are rear-
ranged in the majority of CD41 and CD81 a/b lineage
cells, but they are normally maintained in a transcription-
ally inactive state (26, 29, 30). Rearranged Vg2-Jg1Cg1
genes, in particular, are present in most a/b lineage cells
but are completely repressed. To determine if the transcrip-
tion of endogenous rearranged TCR-g genes can also be
influenced by IL-7R–mediated signals, we tested whether
IL-7 can activate expression of endogenous TCR-g genes
in a/b lineage cells from normal mice. In contrast to im-
mature DP thymocytes, the majority of CD41 SP mature
thymocytes from B6 mice express the IL-7Ra chain (31;
and data not shown). A significant fraction of CD81 SP
mature thymocytes also express the IL-7Ra chain, but at a
reduced level per cell compared with CD41 thymocytes
(31; and data not shown).
Sorted CD41 or CD81 SP HSAloTCR-a/b1 as well as
CD42CD82TCR-g/d1 thymocytes (all .97% pure) from
B6 mice were cultured in IL-2 for 2 d in the presence or
absence of IL-7, and the level of TCR-g gene transcription
was measured by semiquantitative RT-PCR. The propor-
tion of cells surviving after culture for all different condi-
Figure 4. g/d T cells are not generated in low copy TCR-g transgenic
(loTg) IL-7Ra2/2 mice. Proportions of gated DN thymocytes expressing
TCR-g/d in representative nontransgenic IL-7Ra1/2, low copy TCR-g
transgenic IL-7Ra1/2, and low copy TCR-g transgenic IL-7Ra2/2 lit-
termates. Fractions of TCR-g/d cells that express Vg2 chain are also
compared. Numbers in brackets represent total thymocyte number.
Figure 5. IL-7 induces transcription of endogenous, rearranged TCR-g
genes in purified CD41 a/b thymocytes. (A) Semiquantitative RT-PCR
assay of endogenous, rearranged Vg2-Jg1–specific RNA from sorted
TCR-g/d1 or CD41 or CD81HSAloTCR-b1 thymocytes cultured for
2 d in IL-2 alone (designated as –IL-7) or in medium supplemented with
IL-2 and IL-7 (1% supernatant of transfected IL-7 cDNA–expressing J558
cells, designated as 1IL-7). Addition of IL-7 did not significantly alter the
level of TCR-g gene expression in cultures of g/d thymocytes (data not
shown). Results from threefold serial dilutions of the cDNA samples used
for PCR are shown. The highest amount used for control tubulin PCR
was threefold diluted compared with the highest amount used for Vg2-
Jg1–specific PCR. No product was detected in PCR reactions without
the RT step (data not shown). (B) Kinetics of endogenous Vg2-Jg1 gene
expression in sorted mature a/b thymocytes cultured with 2 ng/ml rIL-7.
RT-PCR products specific for rearranged Vg2-Jg1 and tubulin at various
times after culture (numbers in the boxes refer to hours in culture) were
resolved by gel electrophoresis and visualized by ethidium bromide stain-
ing. Sorted HSAloTCR-b1CD41 or CD81 thymocytes (designated as
CD41 or CD81) were cultured in IL-2 medium with (1) or without (2)
IL-7. No significant TCR-g gene expression was detectable in cultured
CD81 thymocytes or sorted CD41 or CD81 thymocytes at the beginning
of culture (0h). Abundant TCR-g transcripts were detected in DN (puri-
fied by complement kill of CD41 and/or CD81 thymocytes) and sorted
CD251CD442 triple negative cells (pre-T) containing g/d lineage cells.
No product was detected in PCR reactions without the RT step (data
not shown).979 Kang et al.
tions was similar in five independent experiments (data not
shown). Fig. 5 A shows results from one representative
RT-PCR experiment of four assays with identical results.
Consistent with previous results, a/b T cells cultured
without IL-7 failed to express the Vg2-Jg1 gene, despite
the fact that a large fraction of a/b T cells harbor Vg2-Jg1
rearrangements (26). Remarkably, however, IL-7 induced
the expression of the endogenous Vg2-Jg1 TCR-g gene in
mature CD41 SP thymocytes, to a level that was 1/3 to 1/2
the level seen in g/d thymocytes cultured with or without
IL-7 (Fig. 5, data not shown). The induction of transcrip-
tion occurred rapidly after only 5 h in culture, and persisted
until the end of a 4-d culture (Fig. 5 B). Treatment with
IL-7 did not result in a significant induction of rag1/2 gene
expression in these cultures (data not shown). These results
demonstrate that IL-7R signals can induce transcription of
the endogenous rearranged TCR-g gene in CD41 a/b
lineage cells in vitro, and suggest an active role of the
downstream mediators of IL-7R signaling in promoting
transcriptional activities at the TCR-g locus. In contrast to
its effects on CD41 SP thymocytes, IL-7 failed to induce
Vg2-Jg1 TCR-g gene transcription in mature CD8 SP
thymocytes (Fig. 5), perhaps due in part to the lower levels
of IL-7R expression by these cells. The reason for the lack
of transcription of rearranged endogenous TCR-g gene in
CD41 SP thymocytes in vivo is unclear, since IL-7 is pro-
duced by some thymic stromal cells. It appears that CD41
SP thymocytes do not receive sufficient IL-7R signaling in
situ, possibly as a result of limiting local IL-7 concentration
or antagonistic effects of other thymic inductive signals.
Discussion
At least two aspects of T cell precursor differentiation are
regulated by IL-7R–mediated signals. IL-7R signals ensure
survival by preventing programmed cell death of develop-
ing T cells (16, 17), and they directly and specifically regu-
late the production of TCR-g chains. In IL-7Ra2/2 mice,
greatly reduced numbers of a/b thymocytes develop, but
g/d thymocytes are completely absent. Based on the dra-
matically decreased levels of TCR-g, but not -d, -b, and
-a, gene rearrangement observed in thymocytes of IL-
7Ra2/2 mice, it has been suggested that the IL-7R signals
are necessary for activating the TCR-g gene locus (19).
We show here that transcripts emanating from a prerear-
ranged TCR-g transgene are markedly reduced in IL-
7Ra2/2 mice, indicating that IL-7Ra signaling directly
affects TCR-g gene expression, independent of rearrange-
ment. This conclusion is strikingly supported by the studies
showing that IL-7 induces transcription of the endogenous
rearranged Vg2-Jg1Cg1 gene in isolated mature CD41 SP
thymocytes from normal mice. The downstream mediators
of IL-7R have been previously shown to activate germline,
sterile TCR-g transcription in nonlymphocytes (32), con-
sistent with the proposed role of IL-7R in regulating
TCR-g gene transcription.
Equally important, the present data indicate that the
poor expression of TCR-g genes in IL-7Ra2/2 mice is
mainly responsible for the selective deficit of g/d cells in
these mice, since g/d cell development could be restored
with a high copy rearranged TCR-g transgene. The num-
ber of g/d T cells generated per pro-T cell was similar in
the wild-type and high copy transgenic IL-7Ra2/2 mice.
Hence, it appears that the g/d lineage precursor cell gener-
ation, g/d lineage development, and maintenance are not
strictly dependent on IL-7R signals as long as functional
TCR-g chains are present. Since no TCR-d transgene was
provided, these data also suggest that IL-7Ra signaling is
not crucial for TCR-d gene rearrangement and TCR-d
chain production, consistent with previous reports (19, 20).
The residual level of transgene transcription in the high
copy transgenic IL-7Ra2/2 line was probably due to two
factors. First, the high gene dosage provided a greater num-
ber of templates for g gene transcription. Second, adjusting
for gene dosage, it appeared that IL-7Ra deficiency had
somewhat less effect on transcript levels in the high copy
line compared with the low copy line, possibly reflecting a
dysregulation that can occur in multiple tandemly inte-
grated transgenes (33). Nevertheless, transgene transcrip-
tion was substantially reduced in thymocytes of these mice
compared with IL-7Ra1 mice.
In the IL-7Ra2/2 low copy g transgenic mice, no resto-
ration of g/d cell development was observed. Previous
studies showed that the level of transgene-directed g
mRNA in IL-7Ra1 thymocytes harboring the low copy g
transgene is comparable to the level of TCR-g transcripts
in a normal cloned g/d T cell line (29). This level of ex-
pression is sufficient to increase the number of g/d cells in
the thymus of IL-7R1 mice to the same extent as that seen
in the high copy IL-7R1 transgenic mice (23). The IL-7R
mutation is not permissive for this normal level of expres-
sion, and the sharp reduction in expression is sufficient to
completely prevent g/d cell development. This finding
suggests that the deficiency in TCR-g transcription in IL-
7Ra2/2 mice could account for the lack of g/d cells in
these mice even if the locus underwent rearrangement nor-
mally.
However, it is likely that TCR-g gene rearrangement is
also affected in IL-7Ra2/2 mice. Although it might be
proposed that the low levels of TCR-g gene rearrange-
ments observed in IL-7Ra2/2 thymi are due to the rapid
turnover of cells that have rearranged TCR-g genes but
do not survive as a result of the lack of IL-7R signaling, this
is unlikely to be the complete explanation. Previous studies
have shown that the majority of TCR-g gene rearrange-
ments in the normal thymus are nonproductive ones in
a/b lineage CD41CD81 DP thymocytes (34). The IL-
7Ra2/2 mice we examined contained appreciable percent-
ages of DP and SP ab thymocytes, yet TCR-g gene rear-
rangement was nevertheless sharply reduced. In IL-7Ra2/2
mice, TCR-g gene rearrangements are rare even in a/b
lineage cells, which do not depend on TCR-g/d expres-
sion for survival. This consideration suggests that T cells of
IL-7Ra2/2 mice exhibit a specific deficiency in TCR-g
gene rearrangement. Many previous studies have correlated
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ment (35). For example, enhancer and promoter elements
that support transcription have been shown to play critical
roles in rearrangement of the genes as well. Hence, the de-
fective g gene transcription in IL-7Ra2/2 mice probably
also results in reduced levels of g gene rearrangement.
Two previous reports have provided indirect evidence
for a possible role of IL-7R signals in controlling rear-
ranged TCR-g gene transcription. First, during fetal on-
togeny in gc2/2 mice, rearrangement of some TCR-g
genes was evident, but fetal g/d thymocytes still did not
develop (20). It was not established that this absence of g/d
cells was due to a defect in TCR-g gene transcription. Sec-
ond, in one study of fetal and adult IL-7Ra2/2 mice, it ap-
peared that TCR-g gene rearrangements were not com-
pletely absent as assayed by PCR, but the corresponding
transcripts were undetectable (21). In our hands, IL-7Ra
deficiency reduces the level of thymic g gene rearrange-
ments by at least 40-fold, as detected by genomic Southern
blotting (Fig. 1). In the aforementioned study, it was not
clear whether the level of gene rearrangement detected was
sufficient to result in a measurable quantity of mRNA. Fur-
thermore, it was not established that the rearrangements
that were detected were present in cells that are normally
capable of expressing TCR-g genes. It is known that g
gene expression is extinguished in certain thymic lineages,
such as in CD41CD81 DP cells (29, 30). By using a prere-
arranged transgene present in all thymocyte lineages, we
were able to demonstrate directly that TCR-g gene ex-
pression is impaired in the absence of IL-7Ra signaling.
One other aspect of the data is notable. At 2–3 wk of
age, the total thymocyte number in the high copy TCR-g
transgenic IL-7Ra2/2 mice was only 36% of the number
observed in nontransgenic IL-7Ra2/2 counterparts (Table
I). Thus, the TCR-g transgene expression depressed the
number of thymocytes in IL-7Ra2/2 mice. One possible
explanation for this observation is that TCR-g transgene
expression in young mice enhances the rate of generation
of thymocytes expressing TCR-g/d, resulting in reduced
numbers of a/b lineage cells. Since thymic proliferative
expansion occurs mainly in a/b but not g/d lineage cells,
the reduction in a/b lineage cells would lead to a signifi-
cant reduction in thymic cellularity. A similar effect of the
TCR-g transgene on thymic cellularity has been described
previously in mice that generate a/b lineage cells subopti-
mally (23).
Our results with the G8 (Vg2) TCR-g transgenic IL-
7Ra2/2 mice differ somewhat from a study that employed
a different TCR-g transgene (T3.13.3, Vg1.1) that was
crossed into gc2/2 mice (20). The latter mice contained
only 10% the number of splenic g/d T cells that we ob-
served, although the difference in thymic g/d cell number
was limited to two- to threefold. A plausible explanation
for this difference in peripheral g/d T cell numbers is that
gc-dependent cytokines other than IL-7 may be involved
in the maintenance of mature g/d T cells.
How does the IL-7R regulate TCR-g gene expression?
The TCR Cg1 locus contains a downstream enhancer ele-
ment, 39ECg1 (36, 37). We have recently identified another
regulatory element, called 59HsA, that cooperates with the
39ECg1 to stimulate optimal TCR-g gene rearrangement
and transcription (28). 59HsA is a locus control region
(LCR)-like element that does not exhibit enhancer activity
as measured with transient transfection assays, but is active
when integrated in the genome. It appears to play a role in
rendering the TCR-g locus accessible for gene rearrange-
ment and expression in vivo. 39ECg1 contains a consensus
binding site for signal transducer and activator of transcrip-
tion 5 (STAT5 [38]), a transcription factor that is activated
by JAK1 and JAK3, which are in turn activated by the
IL-7R. 59HsA contains binding sites for other STATs. Re-
portedly, thymocytes of IL-7Ra2/2 mice are devoid of
nuclear STAT5 (21). Further studies will be necessary to
assess the role, if any, that STATs play in TCR-g gene
transcription.
We thank Dr. C. Chambers for helpful discussions and review of the manuscript, P. Schow for expert tech-
nical assistance with flow cytometric cell sorting, and Russell Vance and Dr. A. Volkman for comments on
the paper. 
This work was supported by a grant from the National Institutes of Health (RO1-AI30171). J. Kang is a re-
search fellow of the National Cancer Institute of Canada supported by the Canadian Cancer Society.
Address correspondence to David H. Raulet, Department of Molecular and Cell Biology, 485 Life Sciences
Addition, University of California at Berkeley, Berkeley, CA 94720. Phone: 510-642-9521; Fax: 510-642-
1443; E-mail: raulet@uclink4.berkeley.edu
M. Coles’s present address is Department of Molecular Immunology, National Institute for Medical Re-
search, Mill Hill, London, NW7 1AA, UK.
Submitted: 19 April 1999 Revised: 24 June 1999 Accepted: 29 July 1999981 Kang et al.
References
1. Wiles, M.V., P. Ruiz, and B.A. Imhof. 1992. Interleukin-7
expression during mouse thymus development. Eur. J. Immu-
nol. 22:1037–1042.
2. Kondo, M., I.L. Weissman, and K. Akashi. 1997. Identifica-
tion of clonogenic common lymphoid progenitors in mouse
bone marrow. Cell. 91:661–672.
3. Lin, J.X., T.S. Migone, M. Tsang, M. Friedmann, J.A.
Weatherbee, L. Zhou, A. Yamauchi, E.T. Bloom, J. Mietz,
S. John, et al. 1995. The role of shared receptor motifs and
common Stat proteins in the generation of cytokine pleiot-
ropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15.
Immunity. 2:331–339.
4. von Freeden-Jeffry, U., P. Vieira, L.A. Lucian, T. McNeil,
S.E. Burdach, and R. Murray. 1995. Lymphopenia in inter-
leukin (IL)-7 gene–deleted mice identifies IL-7 as a nonre-
dundant cytokine. J. Exp. Med. 181:1519–1526.
5. Peschon, J.J., P.J. Morrissey, K.H. Grabstein, F.J. Ramsdell,
E. Maraskovsky, B.C. Gliniak, L.S. Park, S.F. Ziegler, D.E.
Williams, C.B. Ware, et al. 1994. Early lymphocyte expan-
sion is severely impaired in interleukin 7 receptor–deficient
mice. J. Exp. Med. 180:1955–1960.
6. DiSanto, J.P., W. Müller, D. Guy-Grand, A. Fischer, and K.
Rajewsky. 1995. Lymphoid development in mice with a tar-
geted deletion of the interleukin 2 receptor gamma chain.
Proc. Natl. Acad. Sci. USA. 92:377–381.
7. Cao, X., E.W. Shores, J. Hu-Li, M.R. Anver, B.L. Kelsall,
S.M. Russell, J. Drago, M. Noguchi, A. Grinberg, E.T.
Bloom, et al. 1995. Defective lymphoid development in
mice lacking expression of the common cytokine receptor
gamma chain. Immunity. 2:223–238.
8. Moore, T.A., U. von Freeden-Jeffry, R. Murray, and A.
Zlotnik. 1996. Inhibition of gd T cell development and early
thymocyte maturation in IL-72/2 mice. J. Immunol. 157:
2366–2373.
9. Plum, J., M. De Smedt, and G. Leclercq. 1993. Exogenous
IL-7 promotes the growth of CD32CD42CD82
CD441CD251/2 precursor cells and blocks the differentia-
tion pathway of TCR-ab cells in fetal thymus organ culture.
J. Immunol. 150:2706–2716.
10. Appasamy, P.M., T.W. Kenniston, Jr., Y. Weng, E.C. Holt,
J. Kost, and W.H. Chambers. 1993. Interleukin 7–induced
expression of specific T cell receptor g variable region genes
in murine fetal liver cultures. J. Exp. Med. 178:2201–2206.
11. Thomis, D.C., C.B. Gurniak, E. Tivol, A.H. Sharpe, and L.J.
Berg. 1995. Defects in B lymphocyte maturation and T lym-
phocyte activation in mice lacking Jak3. Science. 270:794–797.
12. Nosaka, T., J.M. van Deursen, R.A. Tripp, W.E. Thier-
felder, B.A. Witthuhn, A.P. McMickle, P.C. Doherty, G.C.
Grosveld, and J.N. Ihle. 1995. Defective lymphoid develop-
ment in mice lacking Jak3 [published erratum appears in Sci-
ence. 1996. 271:17]. Science. 270:800–802.
13. Park, S.Y., K. Saijo, T. Takahashi, M. Osawa, H. Arase, N.
Hirayama, K. Miyake, H. Nakauchi, T. Shirasawa, and T.
Saito. 1995. Developmental defects of lymphoid cells in Jak3
kinase-deficient mice. Immunity. 3:771–782.
14. Maki, K., S. Sunaga, Y. Komagata, Y. Kodaira, A. Mabuchi,
H. Karasuyama, K. Yokomuro, J.I. Miyazaki, and K. Ikuta.
1996. Interleukin 7 receptor-deficient mice lack gammadelta
T cells. Proc. Natl. Acad. Sci. USA. 93:7172–7177.
15. He, Y.W., and T.R. Malek. 1996. Interleukin-7 receptor a
is essential for the development of gd1 T cells, but not natu-
ral killer cells. J. Exp. Med. 184:289–293.
16. Akashi, K., M. Kondo, U. von Freeden-Jeffry, R. Murray,
and I.L. Weissman. 1997. Bcl-2 rescues T lymphopoiesis in
interleukin-7 receptor-deficient mice. Cell. 89:1033–1041.
17. Maraskovsky, E., L.A. O’Reilly, M. Teepe, L.M. Corcoran,
J.J. Peschon, and A. Strasser. 1997. Bcl-2 can rescue T lym-
phocyte development in interleukin-7 receptor-deficient
mice but not in mutant rag-1 2/2 mice. Cell. 89:1011–1019.
18. Malek, T.R., B.O. Porter, and Y.W. He. 1999. Multiple gc-
dependent cytokines regulate T cell development. Immunol.
Today. 20:71–76.
19. Maki, K., S. Sunaga, and K. Ikuta. 1996. The V-J recombi-
nation of T cell receptor-g genes is blocked in interleukin-7
receptor–deficient mice. J. Exp. Med. 184:2423–2427.
20. Malissen, M., P. Pereira, D.J. Gerber, B. Malissen, and J.P.
DiSanto. 1997. The common cytokine receptor g chain con-
trols survival of g/d T cells. J. Exp. Med. 186:1277–1285.
21. Perumal, N.B., T.W. Kenniston, Jr., D.J. Tweardy, K.F.
Dyer, R. Hoffman, J. Peschon, and P.M. Appasamy. 1997.
TCR-g genes are rearranged but not transcribed in IL-7Ra-
deficient mice. J. Immunol. 158:5744–5750.
22. Muegge, K., M.P. Vila, and S.K. Durum. 1993. Interleukin-
7: a cofactor for V(D)J rearrangement of the T cell receptor
beta gene. Science. 261:93–95.
23. Kang, J., M. Coles, D. Cado, and D.H. Raulet. 1998. The
developmental fate of T cells is critically influenced by
TCRgd expression. Immunity. 8:427–438.
24. Karasuyama, H., and F. Melchers. 1988. Establishment of
mouse cell lines which constitutively secrete large quantities
of interleukin 2, 3, 4 or 5, using modified cDNA expression
vectors. Eur. J. Immunol. 18:97–104.
25. Maniatis, T., E.F. Fritsch, and J. Sambrook. 1989. Molecular
Cloning: A Laboratory Manual. Cold Spring Harbor Labora-
tory, Cold Spring Harbor, NY. 545 pp.
26. Garman, R.D., P.J. Doherty, and D.H. Raulet. 1986. Diver-
sity, rearrangement and expression of murine T cell gamma
genes. Cell. 45:733–742.
27. Dent, A.L., L.A. Matis, F. Hooshmand, S.M. Widacki, J.A.
Bluestone, and S.M. Hedrick. 1990. Self-reactive gd T cells
are eliminated in the thymus. Nature. 343:714–719.
28. Baker, J.E., J. Kang, N. Xiong, T. Chen, D. Cado, and D.H.
Raulet. 1999. A novel element upstream of the Vg2 gene in
the murine T cell receptor g locus cooperates with the 39 en-
hancer to act as a locus control region. J. Exp. Med. 190:669–
680.
29. Kang, J., H.J. Fehling, C. Laplace, M. Malissen, D. Cado,
and D.H. Raulet. 1998. T cell receptor g gene regulatory se-
quences prevent the function of a novel TCRg/pTa pre-T
cell receptor. Immunity. 8:713–721.
30. Ishida, I., S. Verbeek, M. Bonneville, S. Itohara, A. Berns,
and S. Tonegawa. 1990. T-cell receptor gd and g transgenic
mice suggest a role of a g gene silencer in the generation of
ab T cells. Proc. Natl. Acad. Sci. USA. 87:3067–3071.
31. Sudo, T., S. Nishikawa, N. Ohno, N. Akiyama, M. Tama-
koshi, and H. Yoshida. 1993. Expression and function of the
interleukin 7 receptor in murine lymphocytes. Proc. Natl.
Acad. Sci. USA. 90:9125–9129.
32. Quelle, F.W., D. Wang, T. Nosaka, W.E. Thierfelder, D.
Stravopodis, Y. Weinstein, and J.N. Ihle. 1996. Erythropoi-
etin induces activation of Stat5 through association with spe-
cific tyrosines on the receptor that are not required for a mi-
togenic response. Mol. Cell. Biol. 16:1622–1631.
33. Ellis, J., K.C. Tan–Un, A. Harper, D. Michalovich, N. Yan-982 IL-7 Receptor Signals Regulate TCR-g Gene Transcription
noutsos, S. Philipsen, and F. Grosveld. 1996. A dominant
chromatin-opening activity in 59 hypersensitive site 3 of the
human beta-globin locus control region. EMBO (Eur. Mol.
Biol. Organ.) J. 15:562–568.
34. Kang, J., J. Baker, and D. Raulet. 1995. Evidence that pro-
ductive rearrangements of TCRg genes influence the com-
mitment of progenitor cells to differentiate into ab or gd T
cells. Eur. J. Immunol. 25:2706–2709.
35. Sleckman, B.P., J.R. Gorman, and F.W. Alt. 1996. Accessi-
bility control of antigen-receptor variable-region gene assem-
bly: role of cis-acting elements. Annu. Rev. Immunol. 14:
459–481.
36. Spencer, D.M., Y.-H. Hsiang, J.P. Goldman, and D.H. Rau-
let. 1991. Identification of a T-cell-specific transcriptional
enhancer located 39 of Cg1 in the murine T-cell receptor g
locus. Proc. Natl. Acad. Sci. USA. 88:800–804.
37. Kappes, D., C.P. Browne, and S. Tonegawa. 1991. Identifi-
cation of a T-cell-specific enhancer at the locus encoding
T-cell antigen receptor g chain. Proc. Natl. Acad. Sci. USA.
88:2204–2208.
38. Ihle, J.N. 1996. STATs: signal transducers and activators of
transcription. Cell. 84:331–334.